Zhen Shu

613 total citations
18 papers, 484 citations indexed

About

Zhen Shu is a scholar working on Molecular Biology, Immunology and Cancer Research. According to data from OpenAlex, Zhen Shu has authored 18 papers receiving a total of 484 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 9 papers in Immunology and 4 papers in Cancer Research. Recurrent topics in Zhen Shu's work include DNA Repair Mechanisms (3 papers), Immunotherapy and Immune Responses (3 papers) and Cancer-related molecular mechanisms research (3 papers). Zhen Shu is often cited by papers focused on DNA Repair Mechanisms (3 papers), Immunotherapy and Immune Responses (3 papers) and Cancer-related molecular mechanisms research (3 papers). Zhen Shu collaborates with scholars based in China and United States. Zhen Shu's co-authors include Xiaochang Xue, Yingqi Zhang, Nan Mu, Wangqian Zhang, Tonglie Huang, Jintao Gu, Cun Zhang, Qiang Hao, Weina Li and Wei Zhang and has published in prestigious journals such as Nature Communications, Oncogene and Scientific Reports.

In The Last Decade

Zhen Shu

18 papers receiving 478 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhen Shu China 13 252 141 93 78 77 18 484
Libin Yang China 11 244 1.0× 161 1.1× 67 0.7× 42 0.5× 68 0.9× 29 460
Sascha Hasan United States 6 254 1.0× 208 1.5× 189 2.0× 59 0.8× 85 1.1× 9 663
Weihong Yin United States 12 254 1.0× 107 0.8× 67 0.7× 146 1.9× 98 1.3× 15 498
Yanhong Liu China 14 176 0.7× 93 0.7× 116 1.2× 110 1.4× 95 1.2× 31 485
Jian‐Ching Wu Taiwan 12 260 1.0× 111 0.8× 56 0.6× 63 0.8× 74 1.0× 18 472
Xiangde Zhao China 12 310 1.2× 108 0.8× 60 0.6× 35 0.4× 99 1.3× 18 423
Bin Fu China 14 314 1.2× 136 1.0× 53 0.6× 26 0.3× 74 1.0× 29 647
Haifeng Wei China 15 289 1.1× 212 1.5× 60 0.6× 35 0.4× 87 1.1× 24 548
Li Cai China 11 232 0.9× 82 0.6× 129 1.4× 39 0.5× 107 1.4× 21 483
Raquel Grau Spain 8 314 1.2× 109 0.8× 105 1.1× 57 0.7× 75 1.0× 8 543

Countries citing papers authored by Zhen Shu

Since Specialization
Citations

This map shows the geographic impact of Zhen Shu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhen Shu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhen Shu more than expected).

Fields of papers citing papers by Zhen Shu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhen Shu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhen Shu. The network helps show where Zhen Shu may publish in the future.

Co-authorship network of co-authors of Zhen Shu

This figure shows the co-authorship network connecting the top 25 collaborators of Zhen Shu. A scholar is included among the top collaborators of Zhen Shu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhen Shu. Zhen Shu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Shu, Zhen, Bhakti Dwivedi, Jeffrey M. Switchenko, David S. Yu, & Xingming Deng. (2024). PD-L1 deglycosylation promotes its nuclear translocation and accelerates DNA double-strand-break repair in cancer. Nature Communications. 15(1). 6830–6830. 12 indexed citations
2.
Kapoor-Vazirani, Priya, Sandip Kumar Rath, Xu Liu, et al.. (2022). SAMHD1 deacetylation by SIRT1 promotes DNA end resection by facilitating DNA binding at double-strand breaks. Nature Communications. 13(1). 6707–6707. 17 indexed citations
3.
Shu, Zhen, Zhen Li, Huanhuan Huang, et al.. (2020). Cell-cycle-dependent phosphorylation of RRM1 ensures efficient DNA replication and regulates cancer vulnerability to ATR inhibition. Oncogene. 39(35). 5721–5733. 21 indexed citations
4.
Tian, Jiao, Cheng Zeng, Zhen Tian, et al.. (2019). Downregulation of Protein Tyrosine Phosphatase Receptor Type R Accounts for the Progression of Hirschsprung Disease. Frontiers in Molecular Neuroscience. 12. 92–92. 3 indexed citations
5.
Liu, Jun, Yang Lv, Fei Wang, et al.. (2019). miR‐640 aggravates intervertebral disc degeneration via NF‐κB and WNT signalling pathway. Cell Proliferation. 52(5). e12664–e12664. 61 indexed citations
6.
Gao, Yuan, Xiaoju Li, Zhen Shu, et al.. (2018). Nuclear galectin-1-FOXP3 interaction dampens the tumor-suppressive properties of FOXP3 in breast cancer. Cell Death and Disease. 9(4). 416–416. 17 indexed citations
7.
Mu, Nan, Jintao Gu, Nannan Liu, et al.. (2018). PRL-3 is a potential glioblastoma prognostic marker and promotes glioblastoma progression by enhancing MMP7 through the ERK and JNK pathways. Theranostics. 8(6). 1527–1539. 35 indexed citations
8.
Liu, Shuo, Nan Mu, Tonglie Huang, et al.. (2017). A DPP-IV-resistant glucagon-like peptide-2 dimer with enhanced activity against radiation-induced intestinal injury. Journal of Controlled Release. 260. 32–45. 9 indexed citations
9.
Mu, Nan, Jintao Gu, Tonglie Huang, et al.. (2016). A novel NF-κB/YY1/microRNA-10a regulatory circuit in fibroblast-like synoviocytes regulates inflammation in rheumatoid arthritis. Scientific Reports. 6(1). 20059–20059. 127 indexed citations
10.
Huang, Tonglie, Nan Mu, Jintao Gu, et al.. (2016). DDR2–CYR61–MMP1 Signaling Pathway Promotes Bone Erosion in Rheumatoid Arthritis Through Regulating Migration and Invasion of Fibroblast-Like Synoviocytes. Journal of Bone and Mineral Research. 32(2). 407–418. 26 indexed citations
11.
Huang, Tonglie, Jintao Gu, Kuo Zhang, et al.. (2015). Body protective compound-157 enhances alkali-burn wound healing in vivo and promotes proliferation, migration, and angiogenesis in vitro. Drug Design Development and Therapy. 9. 2485–2485. 65 indexed citations
12.
Li, Yumei, et al.. (2014). [Effects of irradiation on proliferation and differentiation of MC3T3-E1 osteoblastic cells in vitro].. PubMed. 32(4). 341–4. 1 indexed citations
13.
Shu, Zhen, Jing Li, Nan Mu, et al.. (2014). Expression, purification and characterization of galectin-1 in Escherichia coli. Protein Expression and Purification. 99. 58–63. 8 indexed citations
15.
Feng, Guodong, Xiaochang Xue, Meili Gao, et al.. (2014). Therapeutic Effects of PADRE-BAFF Autovaccine on Rat Adjuvant Arthritis. BioMed Research International. 2014. 1–9. 14 indexed citations
16.
Yu, Yuecheng, Xiaoyan Shi, Zhen Shu, et al.. (2014). Stromal Cell-Derived Factor-1 (SDF-1)/CXCR4 Axis Enhances Cellular Invasion in Ovarian Carcinoma Cells Via Integrin β1 and β3 Expressions. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics. 21(4). 217–225. 11 indexed citations
17.
Hao, Qiang, Xiaochang Xue, Meng Li, et al.. (2013). Posttranscriptional deregulation of Src due to aberrant miR34a and miR203 contributes to gastric cancer development. BMB Reports. 46(6). 316–321. 15 indexed citations
18.
Hao, Qiang, Weina Li, Cun Zhang, et al.. (2012). TNFα induced FOXP3–NFκB interaction dampens the tumor suppressor role of FOXP3 in gastric cancer cells. Biochemical and Biophysical Research Communications. 430(1). 436–441. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026